42 CFR 403.1202
§ 403.1202 Pricing information.
United States · 42 CFR — Public Health · Status: effective
Cite this
- Citation
- 42 CFR 403.1202, § 403.1202 Pricing information, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/202807
- Permanent ID
ys:prov:202807@1- SHA-256
3a5d2660103368ce3166c5381a180e148dd7485dda32444124fac4fe62cac213
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Any advertisement for any prescription drug or biological product on television (including broadcast, cable, streaming, or satellite) must contain a textual statement indicating the current list price for a typical 30-day regimen or for a typical course of treatment, whichever is most appropriate, as determined on the first day of the quarter during which the advertisement is being aired or otherwise broadcast, as follows: “The list price for a [30-day supply of ] [typical course of treatment with] [name of prescription drug or biological product] is [insert list price]. If you have health insurance that covers drugs, your cost may be different.” Where the price is related to the typical course of treatment and that typical course of treatment varies depending on the indication for which a prescription drug or biological product is prescribed, the list price to be used is the one for the typical course of treatment associated with the primary indication addressed in the advertisement.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.